NEW YORK, Aug. 16, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Hemostasis Diagnostics Market: USA
http://www.reportlinker.com/p0592600/Global-Hemostasis-Diagnostics-Market-USA.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This Country Report provides the following information:
- Sales and market shares of major instrument and reagent suppliers.
- Strategic profiles of leading competitors and emerging market entrants.
- Comprehensive market segmentation analysis.
- Forecasts for over 40 procedures, by country and market segment.
- Review of emerging tests.
- Comparison of over 50 automated and semi-automated analyzers.
- Analysis of innovative technologies.
- Estimates of facilities performing hemostasis tests by country.
- Product development and business expansion opportunities.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Global Hemostasis Diagnostics Market Country Reports are based on both primary and secondary information sources, including interviews with laboratory directors as
well as executives of leading diagnostics companies and start-up firms developing innovative technologies and products.
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Routine and Special Hemostasis Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series
- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
USA
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illnesses
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point-of-Care Testing
c. Home/Self Testing
d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers
Major Product Development Opportunities
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
List of Tables
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin
Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation
Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's
Factor Tests
Worldwide, All Market Segments, Laboratories Performing
Hemostasis Tests By Country, 2010
Worldwide, All Market Segments, Total Hemostasis Test Volume
By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Reagent
Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Instrument
Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Diagnostics
Market By Country, 2010-2020
Executive Summary Table: U.S.A., Total Hemostasis Diagnostics
Market By Market Segment and Product Category, 2010-2020
U.S.A., Laboratories Performing Hemostasis Tests By Market
Segment, 2010
U.S.A., Hospital Laboratories Performing Hemostasis Tests By
Bed Size, 2010
U.S.A., Commercial/Private Laboratories Performing Hemostasis
Tests By Annual Test Volume, 2010
U.S.A., Physician Offices/Group Practices Performing Hemostasis
Tests By Practice Size, 2010
U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
U.S.A., Commercial/Private Laboratories Average Daily Test
Volume, 2010
U.S.A., Physician Offices/Group Practices Average Daily Test
Volume
U.S.A., Total Hemostasis Test Volume By Market Segment,
2010-2020
U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020
U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020
U.S.A., Physician Offices/Group Practices Hemostasis Test Volume,
2010-2020
U.S.A., Commercial/Private Laboratories Hemostasis Test Volume,
2010-2020
U.S.A., Hemostasis Reagent Market By Market Segment,
2010-2020
U.S.A., Major Suppliers of Hemostasis Reagents Estimated
Sales and Market Shares, 2010
U.S.A., Hemostasis Instrument Market By Market Segment,
2010-2020
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated
Total Instrument Placements and Market Shares, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated
Placements and Installed Base By Supplier and Model, 2010
U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated
Instrument Sales and Market Shares, 2010
U.S.A., Total Hemostasis Diagnostics Market By Product
Category, 2010-2020
U.S.A., Major Suppliers of Hemostasis Diagnostic Products,
Estimated Sales and Market Shares, 2010
To order this report:
In Vitro Diagnostic Industry: Global Hemostasis Diagnostics Market: USA
In Vitro Diagnostic Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article